Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026)
Sensus Healthcare (SRTS) posted quarterly Cash from Investing Activities of -$3000.0 for Q1 2026, up 57.14% year-over-year from -$1909.1 in Q1 2025, and up 98.1% quarter-over-quarter from -$158000.0 in Q4 2025.
Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Sensus Healthcare's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 57.14% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$192000.0 (down 284.0% YoY), while the FY2025 annual figure was -$196000.0, up 28.99% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$3000.0, up from -$158000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $15.0 million in Q1 2022, with the low at -$337000.0 in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$18500.0 (2022), against an average of $886187.5.
- Peak annual rise in Cash from Investing Activities reached 18795.0% in 2022, while the deepest fall reached 1900.0% in 2022.
- Sensus Healthcare's Cash from Investing Activities stood at -$10000.0 in 2022, then jumped by 410.0% to $31000.0 in 2023, then soared by 858.06% to $297000.0 in 2024, then tumbled by 153.2% to -$158000.0 in 2025, then jumped by 98.1% to -$3000.0 in 2026.
- Business Quant data shows SRTS's Cash from Investing Activities at -$3000.0 in Q1 2026, -$158000.0 in Q4 2025, and -$4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Sensus Healthcare | 52.18 Mn | 37.00 Mn | - | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Sep 30, 2023 | 31,000.00 |